H & I Critical Care

H&I Critical Care is a specialized pharmaceutical company based in India, operating as a prominent division of Alna Biotech. The company is dedicated to the manufacturing, marketing, and distribution of a comprehensive range of critical care medicines, including injectables, infusions, tablets, and capsules. Its extensive product portfolio features life-saving treatments such as Meropenem, Enoxaparin, and Human Normal Albumin, catering to intensive care units and emergency departments. H&I Critical Care operates primarily through a PCD (Propaganda Cum Distribution) pharma franchise model, providing monopoly rights and marketing support to its partners across India. The company's manufacturing processes adhere to stringent WHO-GMP and ISO 9001 standards, ensuring high quality and efficacy in every dose. By focusing on affordability and innovation in the critical care segment, H&I Critical Care has established itself as a trusted partner for healthcare professionals and hospitals nationwide.